Solventum Cash Flow Statement
NYSE: SOLVHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Solventum free cash flow
In fiscal 2025, Solventum generated $369.0 million of operating cash flow and spent $379.0 million on capital expenditures. That left free cash flow of -$10.0 million, a free-cash-flow margin of -0.1% of revenue. Free cash flow was down 101.2% from the prior year's $805.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Solventum cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 |
|---|---|---|---|---|
| Net Income | 1.56B | 479.00M | 1.35B | 1.34B |
| Net Income growth (YoY) | +224.84% | -64.41% | +0.22% | — |
| Depreciation & Amortization | 489.00M | 555.00M | 561.00M | 578.00M |
| Stock-Based Compensation | 161.00M | 112.00M | 39.00M | 37.00M |
| Change in Working Capital | -1.00M | 177.00M | -1.00M | -89.00M |
| Operating Cash Flow | 369.00M | 1.19B | 1.92B | 1.68B |
| Capital Expenditures | -379.00M | -380.00M | -290.00M | -251.00M |
| Investing Cash Flow | 2.80B | -380.00M | -230.00M | -253.00M |
| Debt Issued | 0 | 8.30B | 0 | 0 |
| Debt Repaid | -3.07B | -300.00M | 0 | 0 |
| Financing Cash Flow | -3.06B | -240.00M | -1.55B | -1.46B |
| Net Change in Cash | 116.00M | 568.00M | 133.00M | -30.00M |
| Free Cash Flow | -10.00M | 805.00M | 1.63B | 1.43B |
This table shows 4 annual periods of Solventum's cash flow statement, from FY 2025 back to FY 2022, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SOLV's reporting calendar. What is a cash flow statement?